Acute cardiac failure and hepatic ischemia induced by disopyramide phosphate.
Two patients abruptly developed congestive heart failure and elevation in serum transaminase levels when given disopyramide phosphate; enzyme abnormalities and hemodynamic status corrected upon withdrawal of the drug. Both patients had underlying ischemic cardiomyopathy. Myocardial infarction, pulmonary embolism, and viral hepatitis were ruled out in both patients. One patient had a liver biopsy documenting central hepatic necrosis with congestion, consistent with hepatic ischemia and not toxic hepatitis. In the other patient, cardiac decompensation and hepatocellular enzyme elevation were reproduced on rechallenge with the drug. Disopyramide should be used with caution in patients with heart failure.
D000208:Acute Disease; D001219:Aspartate Aminotransferases / Q000097:blood; D056486:Chemical and Drug Induced Liver Injury / Q000175:diagnosis; D004206:Disopyramide / Q000009:adverse effects*; D006333:Heart Failure / Q000209:etiology*; D006801:Humans; D007511:Ischemia / Q000209:etiology*; D008099:Liver / Q000098:blood supply* / Q000201:enzymology / Q000473:pathology; D008297:Male; D008875:Middle Aged; D011725:Pyridines / Q000009:adverse effects*
D011725:Pyridines; D001219:Aspartate Aminotransferases; D004206:Disopyramide